Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR)

被引:2
|
作者
Devpura, S. [1 ]
Siddiqui, M. S. [1 ]
Chen, D. [1 ]
Liu, D. [1 ]
Li, H. [1 ]
Kumar, S. [1 ]
Gordon, J. [1 ]
Ajlouni, M. [1 ]
Movsas, B. [1 ]
Chetty, I. J. [1 ]
机构
[1] Henry Ford Hlth Syst, Detroit, MI 48202 USA
关键词
MONTE-CARLO; RADIATION-THERAPY; PHOTON BEAMS; ALGORITHM; VMC;
D O I
10.1088/1742-6596/489/1/012007
中图分类号
O59 [应用物理学];
学科分类号
摘要
The purpose of this study was to systematically evaluate dose distributions computed with 5 different dose algorithms for patients with lung cancers treated using stereotactic ablative body radiotherapy (SABR). Treatment plans for 133 lung cancer patients, initially computed with a 1D-pencil beam (equivalent-path-length, EPL-1D) algorithm, were recalculated with 4 other algorithms commissioned for treatment planning, including 3-D pencil-beam (EPL-3D), anisotropic analytical algorithm (AAA), collapsed cone convolution superposition (CCC), and Monte Carlo (MC). The plan prescription dose was 48 Gy in 4 fractions normalized to the 95% isodose line. Tumors were classified according to location: peripheral tumors surrounded by lung (lung-island, N=39), peripheral tumors attached to the rib-cage or chest wall (lung-wall, N=44), and centrally-located tumors (lung-central, N=50). Relative to the EPL-1D algorithm, PTV D95 and mean dose values computed with the other 4 algorithms were lowest for "lung-island" tumors with smallest field sizes (3-5 cm). On the other hand, the smallest differences were noted for lung-central tumors treated with largest field widths (7-10 cm). Amongst all locations, dose distribution differences were most strongly correlated with tumor size for lung-island tumors. For most cases, convolution/superposition and MC algorithms were in good agreement. Mean lung dose (MLD) values computed with the EPL-1D algorithm were highly correlated with that of the other algorithms (correlation coefficient =0.99). The MLD values were found to be similar to 10% lower for small lung-island tumors with the model-based (conv/superposition and MC) vs. the correction-based (pencil-beam) algorithms with the model-based algorithms predicting greater low dose spread within the lungs. This study suggests that pencil beam algorithms should be avoided for lung SABR planning. For the most challenging cases, small tumors surrounded entirely by lung tissue (lung-island type), a Monte-Carlo-based algorithm may be warranted.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Evaluating dose coverage and conformity in stereotactic ablative body radiotherapy (SABR) plans
    O'Keeffe, Serena
    Fleming, Cathy
    Vintro, Luis Leon
    Mcclean, Brendan
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2024, 118
  • [2] Spatial Assessment of Dose Distributions for Patients with Lung Cancer Treated with Stereotactic Ablative Radiotherapy (SABR)
    Liu, D.
    Chen, D.
    Chetvertkov, M.
    Altman, M.
    Li, H.
    Wen, N.
    Glide-Hurst, C.
    Ajlouni, M.
    Levin, K.
    Movsas, B.
    Chetty, I.
    MEDICAL PHYSICS, 2012, 39 (06) : 3817 - 3817
  • [3] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer
    Desai, Neil B.
    Laine, Aaron M.
    Timmerman, Robert D.
    BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
  • [4] A case for development of stereotactic ablative body radiotherapy (SABR) for lung cancer at Aberdeen
    Stilwell, C.
    Steven, E.
    Sharma, R. N.
    Bissett, D.
    Shrimali, R. K.
    LUNG CANCER, 2013, 79 : S58 - S59
  • [5] Prognostic role of texture analysis in lung cancer treated with stereotactic ablative radiotherapy (SABR)
    Nardone, V.
    Tini, P.
    Mazzoni, L. N.
    La Penna, A.
    Biondi, M.
    Sebaste, L.
    Carfagno, T.
    Vanzi, E.
    De Otto, G.
    Battaglia, G.
    Pastina, P.
    Carbone, S. F.
    Buonamici, F. Banci
    Pirtoli, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
    Goldsmith, Christy
    Gaya, Andrew
    CANCER IMAGING, 2012, 12 (02): : 351 - 360
  • [7] A national program for the implementation of lung Stereotactic Ablative Body Radiotherapy (SABR)
    Diez, P.
    Haridass, A.
    Lilley, J.
    Patel, R.
    Miles, E.
    Tree, A.
    Clark, C.
    Dean, C.
    Fell, K.
    McDonald, F.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S868 - S870
  • [8] Stereotactic Ablative Body Radiotherapy for Lung Cancer
    Franks, K. N.
    Jain, P.
    Snee, M. P.
    CLINICAL ONCOLOGY, 2015, 27 (05) : 280 - 289
  • [9] Stereotactic ablative body radiotherapy (SABR) for multiple lung tumours: hazardous or harmless?
    Allos, B.
    Carruthers, H.
    Harrop, V.
    Stange, D.
    Misheva, T.
    Stevenson, R.
    Watkins, S.
    Ghafoor, Q.
    LUNG CANCER, 2018, 115 : S58 - S58
  • [10] Stereotactic ablative body radiotherapy (SABR) for the radical treatment of early lung cancer: initial outcomes from the Southwest Peninsula regional SABR MDT
    Cope, Victoria
    Goranov, Bojidar
    Eleanor, Weir
    Park, Sarah
    Richters, Megan
    Kingdon, Sarah
    Gordon, Tanya
    Rangegowda, Sanjay
    Aldridge, Robin
    Ford, Victoria
    LUNG CANCER, 2025, 200